Article
Mutational architecture defines disease behaviour in an Indian cohort of Myeloproliferative Neoplasms: Foundations for a Genomics-first classification.
Leukemia research - 1 Jun 2026
Singh Suvir, Jain Kunal, Dhillon Barjinderjit, Narang Vikram, Pandita Renu Moti, Singh Jagdeep, Grewal Gurvinder Singh
Abstract excerpt
AIMS: Data on BCR::ABL1-negative MPN genomics in India are limited. We aimed to define mutational architecture and evaluate co-mutation burden for risk stratification. METHODS: We analysed 179 patients (median age 57 years; 36.3% ≤50 years). Targeted NGS covering relevant myeloid genes was performed in 104 patients (58%). Prognostic factors and latent molecular subgroups were evaluated using Cox proportional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
